Lv4
608 积分 2024-06-28 加入
Anlotinib in progressive RAI-refractory differentiated thyroid cancer: long-term results and PET/CT prognostic markers
1个月前
已完结
Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer
2个月前
已完结
Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Preliminary Latin American Experience
2个月前
已完结
Neoadjuvant Therapy with Multikinase Inhibitors for Locally Advanced Differentiated Thyroid Cancer: A Systematic Review
2个月前
已完结
Neoadjuvant Therapy with Multikinase Inhibitors for Locally Advanced Differentiated Thyroid Cancer: A Systematic Review
2个月前
已关闭
Sequencing antibody–drug conjugates in metastatic breast cancer: A systematic review
2个月前
已完结
Long-Term Clinical Outcomes of Patients with Differentiated Thyroid Cancer Treated with Lenvatinib: Results from Real-World Practice in Japan
2个月前
已完结
Mechanisms of resistance to antibody-drug conjugates in breast cancer
2个月前
已完结
Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Preliminary Latin American Experience
3个月前
已完结
An update on redifferentiation strategies for radioactive iodine-refractory differentiated thyroid carcinoma
6个月前
已完结
BAT mitochondria: whitening meets softening
11个月前
已采纳
Tripeptide armour shields encapsulated proteins
11个月前
已采纳
Tripeptide armour shields encapsulated proteins
11个月前
已采纳
Tripeptide armour shields encapsulated proteins
11个月前
已采纳
Efficacy and safety of tirzepatide, GLP‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis
1年前
已撤回
Colibactin‐positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer
1年前
已采纳
Gastric precancerous process in a high risk population: cohort follow-up
1年前
已采纳
皖公网安备34019202002308
